Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Clinical Trial Regulation Conference
SESSION 3: TECHNICAL ISSUES
Session Chair(s)
Judith Creba, PhD
- Executive Director, EU Regulatory Strategy
- Novartis Pharma AG, Switzerland
Speaker(s)
Annex VI: Discussion of the Key Issues and How to Address Them
Sini Eskola, MPharm, MSc
- Director Regulatory Affairs
- European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Implementation Guidance and Delegated Acts - Awareness of and the Key Identified Issues from the Draft Guidance
Isabelle Clamou
- Regulatory affairs Director - EU Policy
- Amgen Ltd, Belgium

Maja Leon-Grzymkowska
- Legal Officer at European Commission
- European Commission, Belgium
Contact us
Registration Questions